Effect of Kinesiotaping in Different Directions on Muscle

May 8, 2020 updated by: Hilal UZUNLAR, Muğla Sıtkı Koçman University

Effect of Kinesiotaping in Different Directions on Muscle Endurance in Healthy Individuals

The study was conducted to investigate the effects of different Kinesio taping directions on dynamic muscle endurance. This randomized, double-blind, crossover study was implemented on 27 healthy male subjects. Before the study, personal and demographic information of the volunteers were recorded and muscle strength was evaluated in the biceps curl position with 1 maximum repetition technique. One week after this first evaluation muscle endurance was evaluated by counting the accurate elbow flexions completed in biceps curl position with 80% weight of 1 maximum repetition recorded in the first evaluation. Following this second evaluation facilitation, inhibition, and placebo tapings were applied to all the 27 subjects who were randomly assigned into 3 groups sequentially with an interval of two days. The sequence of taping technique to be used for the groups were also randomly determined and applied to the M. Biceps Brachii and muscle endurance was evaluated with the same method half-hour after the tape was applied. All the evaluations were performed by the same evaluator who was blind to the taping technique.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Facilitation taping was applied from the origins of the muscle to the insertion. Inhibition taping was applied from the insertio of the muscle to the origin. Facilitation taping and inhibition taping was applied on the target tissue with 25% tension. Y-band was used during facilitation taping and inhibition taping. It was applied to individuals with shoulder mild abduction, external rotation, elbow extension and supination position. Placebo taping was applied while in a resting position. In placebo taping, it was applied using two I bands in horizontal direction. In placebo taping, no tension was applied to the tapes. Evaluations were made while the subjects were standing. The biceps curl exercise position starts with the palms facing the trunk. Elbow flexion is completed by making full range of motion. The cases were randomized into 3 groups: group-1 facilitation taping, group-2 inhibition taping and group-3 placebo taping.The treatment sequence to be applied to the patients was determined by randomization. Facilitation, inhibition and placebo banding were applied to the patients, respectively. Accordingly, inhibition and placebo taping was applied to the cases that started with the facilitation taping. Placebo and facilitation banding were applied to the patients that started with inhibition banding, respectively. Facilitation and inhibition banding was applied to the cases that started with placebo banding, respectively. During the evaluation, banding application was kept by wearing plenty of clothes. Evaluators and subjects participating in the study did not have knowledge and experience about the taping method.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
27

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Mugla, Turkey, 48000
        • Mugla Sıtkı Kocman University Health Sciences Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

14 years to 23 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Being a male university student over the age of 18
  • Volunteering for the study
  • Fiiling out the informed consent form not having the knowledge and experience about kinesiotaping before

Exclusion Criteria:

  • Anabolic agent users
  • Having any neurological disease or systemic disease
  • Having undergone spine and upper extremity surgery
  • Skin sensitivity to elastic banding
  • Open wound, ulser, fungal infection in the area to be taped
  • Exposure to upper extremity and/or spinal injury in the past 6 months
  • To have used alcohol, caffeine-containing substances and pain medication in the last 24 hours before the evaluation.
  • To have been involved in physical activity and / or activities in the last 48 hours prior to the evaluation, other than routine work, that will tire the upper limbs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Grup 1- Facilitation
It consists of cases that start with the taping of the facilitation.
Other: FACILITATION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps brachii muscle. Taping was done with 25% tension with Y tape from the origin to insertion of the muscle.
Other: INHIBITION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps braki muscle. Taping was done with 25% tension with Y tape from the insertio to origo of the muscle.
Other: PLACEBO TAPING
Unlike Kinesio taping muscle technique, it was performed with horizontal taping on the muscle. The ends of the kinesio tapes will be applied tension-free without overlapping with I tape.
Experimental: Grup 2- İnhibition
It consists of cases that start with the taping of the inhibition.
Other: FACILITATION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps brachii muscle. Taping was done with 25% tension with Y tape from the origin to insertion of the muscle.
Other: INHIBITION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps braki muscle. Taping was done with 25% tension with Y tape from the insertio to origo of the muscle.
Other: PLACEBO TAPING
Unlike Kinesio taping muscle technique, it was performed with horizontal taping on the muscle. The ends of the kinesio tapes will be applied tension-free without overlapping with I tape.
Placebo Comparator: Grup 3- Plasebo
It consists of cases that start with the taping of the placebo.
Other: FACILITATION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps brachii muscle. Taping was done with 25% tension with Y tape from the origin to insertion of the muscle.
Other: INHIBITION TAPING
The muscle technique, which is a kinesio tape technique, will be used in the biceps braki muscle. Taping was done with 25% tension with Y tape from the insertio to origo of the muscle.
Other: PLACEBO TAPING
Unlike Kinesio taping muscle technique, it was performed with horizontal taping on the muscle. The ends of the kinesio tapes will be applied tension-free without overlapping with I tape.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Number of Elbow Flexion
Time Frame: 2 minutes
Muscle endurance was found by recording the number of elbow flexions performed within 1 minute in the biceps curl exercise position against moderate violence at the rate of 80% of 1 maximum repetition. Facilitation taping, inhibition taping and placebo taping were applied to 27 subjects randomized to 3 groups at two consecutive day intervals. The order of taping was also determined by randomization method and performed on the biceps braki muscle in the dominant limb of the subjects, and muscle endurance was evaluated half an hour after taping.
2 minutes

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Maximum of 1 Repetition (1-MT)
Time Frame: 10 minutes
Muscle strength was found with a maximum of 1 repetition (1-MT) in the biceps curl exercise position. The subjects were asked to perform the movement against resistance with the greatest weight predicted during this evaluation position. When he was able to repeat the movement a second time or more, we continued by adding 5 kg, 3 kg, 2 kg or 1 kg weights, respectively. 1-MT was found by giving 1 minute rest intervals between repeated trials.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Muğla Sıtkı Koçman University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 2, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 13, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 12, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 6, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 6, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 7, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 12, 2020

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 8, 2020

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 190079

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings